Despite affecting 55 million people worldwide, Alzheimer’s disease still has no cure. But recent advancements in the field have seen a number of promising drugs that can slow the disease’s progression pass late-stage clinical trials.
Despite affecting 55 million people worldwide, Alzheimer’s disease still has no cure. But recent advancements in the field have seen a number of promising drugs that can slow the disease’s progression pass late-stage clinical trials.